Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

Recruiting now · Not applicable

Conditions studied: Chronic Kidney Disease(CKD), Type 2 DM, Type 2 Diabetes Mellitus (T2DM)

In brief

IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.

Key facts

Study ID

NCT06906627

Run by

Duke University

People needed

750

Starts

2025-10-28

Expected to finish

2027-04-01

Last updated by the study team

2026-06-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults with type 2 diabetes (T2D)
• Receiving primary care within the healthcare system, Primary Care Provider (PCP) visit within the past 24 months (any PCP provider, including APP).
• Lack of estimated glomerular filtration rate (eGFR) and/or urine albumin- creatinine ratio (UACR) measurement in the prior 15 months within the EHR

You may not qualify if…

• Chronic kidney disease (CKD) diagnosis

Where it is running

• University of Alabama — Birmingham, Alabama, United States (enrolling)
• Orlando Health — St. Petersburg, Florida, United States (enrolling)
• University of Michigan — Ann Arbor, Michigan, United States (enrolling)
• Essentia Health — Duluth, Minnesota, United States (enrolling)
• Duke University — Durham, North Carolina, United States (enrolling)
• Houston Methodist — Houston, North Carolina, United States (enrolling)
• Baylor Scott & White — Temple, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.